These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9836184)

  • 1. [Single and 2-week repeated intravenous dose toxicity studies of disodium mercaptoundecahydro-closo-dodecaborate in rats].
    Itoh F; Yabuuchi K; Ohno K; Ikeuchi I; Muraoka Y
    J Toxicol Sci; 1998 Oct; 23 Suppl 4():587-611. PubMed ID: 9836184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and excretion of boron after intravenous administration of disodium mercaptoundecahydro-closo-dodecaborate to rats.
    Yamaguchi T; Nakajima Y; Miyamoto H; Mizobuchi M; Kanazu T; Kadono K; Nakamoto K; Ikeuchi I
    J Toxicol Sci; 1998 Oct; 23 Suppl 4():577-85. PubMed ID: 9836183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reverse mutation test of disodium mercaptoundecahydro-closo-dodecaborate with bacteria].
    Miyake Y; Nishimoto Y
    J Toxicol Sci; 1998 Oct; 23 Suppl 4():613-8. PubMed ID: 9836185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boron neutron capture therapy: long-term effects on the skin and spinal cord of the rat.
    Morris GM; Constantine G; Ross G; Yeung TK; Hopewell JW
    Radiat Res; 1993 Sep; 135(3):380-6. PubMed ID: 8378531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution of (10)B for Boron Neutron Capture Therapy (BNCT) in a mouse model after injection of sodium mercaptoundecahydro-closo-dodecaborate and l-para-boronophenylalanine.
    Wittig A; Huiskamp R; Moss RL; Bet P; Kriegeskotte C; Scherag A; Hilken G; Sauerwein WA
    Radiat Res; 2009 Oct; 172(4):493-9. PubMed ID: 19772470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium mercaptoundecahydro-closo-dodecaborate (BSH), a boron carrier that merits more attention.
    Wittig A; Stecher-Rasmussen F; Hilger RA; Rassow J; Mauri P; Sauerwein W
    Appl Radiat Isot; 2011 Dec; 69(12):1760-4. PubMed ID: 21420870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney function changes in rats after single-dose administration of borocaptate sodium.
    Horn V; Buchar E; Janků I
    Physiol Res; 1997; 46(4):279-83. PubMed ID: 9728493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New functionalized mercaptoundecahydrododecaborate derivatives for potential application in boron neutron capture therapy: synthesis, characterization and dynamic visualization in cells.
    Genady AR; Ioppolo JA; Azaam MM; El-Zaria ME
    Eur J Med Chem; 2015 Mar; 93():574-83. PubMed ID: 25748122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of rat skin to boron neutron capture therapy with p-boronophenylalanine or borocaptate sodium.
    Morris GM; Coderre JA; Hopewell JW; Micca PL; Rezvani M
    Radiother Oncol; 1994 Aug; 32(2):144-53. PubMed ID: 7972908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the subcellular distribution of mercaptoundecahydro-closo-dodecaborate (BSH) in human glioblastoma multiforme by electron microscopy.
    Neumann M; Kunz U; Lehmann H; Gabel D
    J Neurooncol; 2002 Apr; 57(2):97-104. PubMed ID: 12125978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell type selective accumulation of mercaptoundecahydro- closo-dodecaborate (BSH) in glioblastoma multiforme.
    Neumann M; Bergmann M; Gabel D
    Acta Neurochir (Wien); 2003 Nov; 145(11):971-5. PubMed ID: 14628202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
    Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenic effect of borocaptate sodium and boronophenylalanine in neutron capture therapy.
    Kinashi Y; Masunaga S; Ono K
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):562-7. PubMed ID: 12243836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diuretic effect of borocaptate sodium in rats and in patients with brain tumors.
    Horn V; Slánsky J; Buchar E; Janku I; Sourek K; Tovarys F
    Methods Find Exp Clin Pharmacol; 1997 Oct; 19(8):559-66. PubMed ID: 9442480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dependent disposition kinetics and tissue accumulation of boron after intravenous injections of sodium mercaptoundecahydrododecaborate in rabbits.
    Buchar E; Bednárová S; Grüner B; Walder P; Strouf O; Janků I
    Cancer Chemother Pharmacol; 1992; 29(6):450-4. PubMed ID: 1568287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boron biodistribution for BNCT in the hamster cheek pouch oral cancer model: combined administration of BSH and BPA.
    Garabalino MA; Heber EM; Monti Hughes A; Pozzi EC; Molinari AJ; Nigg DW; Bauer W; Trivillin VA; Schwint AE
    Appl Radiat Isot; 2014 Jun; 88():64-8. PubMed ID: 24360859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption.
    Yang W; Barth RF; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):663-72. PubMed ID: 9112465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boron neutron capture therapy of brain tumors: biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas.
    Goodman JH; Yang W; Barth RF; Gao Z; Boesel CP; Staubus AE; Gupta N; Gahbauer RA; Adams DM; Gibson CR; Ferketich AK; Moeschberger ML; Soloway AH; Carpenter DE; Albertson BJ; Bauer WF; Zhang MZ; Wang CC
    Neurosurgery; 2000 Sep; 47(3):608-21; discussion 621-2. PubMed ID: 10981748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
    Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.